These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 16964310)

  • 1. TAT-mediated intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in mice.
    Toro A; Grunebaum E
    J Clin Invest; 2006 Oct; 116(10):2717-26. PubMed ID: 16964310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular delivery of purine nucleoside phosphorylase (PNP) fused to protein transduction domain corrects PNP deficiency in vitro.
    Toro A; Paiva M; Ackerley C; Grunebaum E
    Cell Immunol; 2006 Apr; 240(2):107-15. PubMed ID: 16930574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebellar abnormalities in purine nucleoside phosphorylase deficient mice.
    Mansouri A; Min W; Cole CJ; Josselyn SA; Henderson JT; van Eede M; Henkelman RM; Ackerley C; Grunebaum E; Roifman CM
    Neurobiol Dis; 2012 Aug; 47(2):201-9. PubMed ID: 22521465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kinetics and tissue distribution of protein transduction in mice.
    Cai SR; Xu G; Becker-Hapak M; Ma M; Dowdy SF; McLeod HL
    Eur J Pharm Sci; 2006 Mar; 27(4):311-9. PubMed ID: 16376528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentivirus gene therapy for purine nucleoside phosphorylase deficiency.
    Liao P; Toro A; Min W; Lee S; Roifman CM; Grunebaum E
    J Gene Med; 2008 Dec; 10(12):1282-93. PubMed ID: 18924118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of proliferative responses in purine nucleoside phosphorylase (PNP)-deficient T lymphocytes by retroviral-mediated PNP gene transfer and expression.
    Nelson DM; Butters KA; Markert ML; Reinsmoen NL; McIvor RS
    J Immunol; 1995 Mar; 154(6):3006-14. PubMed ID: 7876563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purine nucleoside phosphorylase deficiency.
    Markert ML
    Immunodefic Rev; 1991; 3(1):45-81. PubMed ID: 1931007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mutations and hot-spots in patients with purine nucleoside phosphorylase deficiency.
    Grunebaum E; Zhang J; Roifman CM
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1411-5. PubMed ID: 15571269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of purine nucleoside phosphorylase deficiency on thymocyte development.
    Papinazath T; Min W; Sujiththa S; Cohen A; Ackerley C; Roifman CM; Grunebaum E
    J Allergy Clin Immunol; 2011 Oct; 128(4):854-863.e1. PubMed ID: 21868080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies.
    Grunebaum E; Cohen A; Roifman CM
    Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):630-8. PubMed ID: 24113229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo sensitization of ovarian tumors to chemotherapy by expression of E. coli purine nucleoside phosphorylase in a small fraction of cells.
    Gadi VK; Alexander SD; Kudlow JE; Allan P; Parker WB; Sorscher EJ
    Gene Ther; 2000 Oct; 7(20):1738-43. PubMed ID: 11083495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of CEA with both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC vaccination.
    Kim SG; Park MY; Kim CH; Sohn HJ; Kim HS; Park JS; Kim HJ; Oh ST; Kim TG
    Vaccine; 2008 Nov; 26(50):6433-40. PubMed ID: 18812201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial Purine Nucleoside Phosphorylase Deficiency Helps Determine Minimal Activity Required for Immune and Neurological Development.
    Grunebaum E; Campbell N; Leon-Ponte M; Xu X; Chapdelaine H
    Front Immunol; 2020; 11():1257. PubMed ID: 32695102
    [No Abstract]   [Full Text] [Related]  

  • 14. Intracellular Delivery of Human Purine Nucleoside Phosphorylase by Engineered Diphtheria Toxin Rescues Function in Target Cells.
    Park M; Xu X; Min W; Sugiman-Marangos SN; Beilhartz GL; Adams JJ; Sidhu SS; Grunebaum E; Melnyk RA
    Mol Pharm; 2018 Nov; 15(11):5217-5226. PubMed ID: 30212635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction of purine nucleoside phosphorylase deficiency by retroviral-mediated gene transfer in mouse S49 T cell lymphoma: a model for gene therapy of T cell immunodeficiency.
    Foresman MD; Nelson DM; McIvor RS
    Hum Gene Ther; 1992 Dec; 3(6):625-31. PubMed ID: 1482702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of immunodeficiency caused by a purine nucleoside phosphorylase defect by using tandem mass spectrometry on dried blood spots.
    la Marca G; Canessa C; Giocaliere E; Romano F; Malvagia S; Funghini S; Moriondo M; Valleriani C; Lippi F; Ombrone D; Della Bona ML; Speckmann C; Borte S; Brodszki N; Gennery AR; Weinacht K; Celmeli F; Pagel J; de Martino M; Guerrini R; Wittkowski H; Santisteban I; Bali P; Ikinciogullari A; Hershfield M; Notarangelo LD; Resti M; Azzari C
    J Allergy Clin Immunol; 2014 Jul; 134(1):155-9. PubMed ID: 24767876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular delivery of a Tat-eGFP fusion protein into muscle cells.
    Caron NJ; Torrente Y; Camirand G; Bujold M; Chapdelaine P; Leriche K; Bresolin N; Tremblay JP
    Mol Ther; 2001 Mar; 3(3):310-8. PubMed ID: 11273772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of HIV-1 Tat traffic and function by transduction-competent single chain antibodies.
    Theisen DM; Pongratz C; Wiegmann K; Rivero F; Krut O; Krönke M
    Vaccine; 2006 Apr; 24(16):3127-36. PubMed ID: 16497417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial deficiency of purine nucleoside phosphorylase: studies of purine and pyrimidine metabolism.
    Edwards NL; Gelfand EW; Biggar D; Fox IH
    J Lab Clin Med; 1978 May; 91(5):736-49. PubMed ID: 417142
    [No Abstract]   [Full Text] [Related]  

  • 20. Full-length proteins attached to the HIV tat protein transduction domain are neither transduced between cells, nor exhibit enhanced immunogenicity.
    Leifert JA; Harkins S; Whitton JL
    Gene Ther; 2002 Nov; 9(21):1422-8. PubMed ID: 12378404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.